Bioscience Animal Health PCL
Bioscience Animal Health Public Company Limited manufactures and distributes pharmaceutical supplies, devices, and equipment in Thailand. The company offers bioscience products, such as antibiotics, additives, injections, mold inhibitors, water-soluble products, vaccines, hormones, and Bismix B and SD series. It also provides products for livestock and pets, as well as trading services. The compa… Read more
Bioscience Animal Health PCL (BIS) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.126x
Based on the latest financial reports, Bioscience Animal Health PCL (BIS) has a cash flow conversion efficiency ratio of 0.126x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (฿102.05 Million) by net assets (฿810.31 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Bioscience Animal Health PCL - Cash Flow Conversion Efficiency Trend (2019–2024)
This chart illustrates how Bioscience Animal Health PCL's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Bioscience Animal Health PCL Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Bioscience Animal Health PCL ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Refined Metals Corp.
PINK:RFMCF
|
0.642x |
|
WiSA Technologies Inc
NASDAQ:WISA
|
-0.074x |
|
Finlay Minerals Ltd
OTCQB:FYMNF
|
0.037x |
|
Thai Wire Products Public Company Limited
BK:TWP
|
-0.050x |
|
Biotron Limited
PINK:BITRF
|
-0.322x |
|
Binect AG
XETRA:MA10
|
0.012x |
|
SE-Education Public Company Limited
BK:SE-ED
|
-0.026x |
|
Evolva Holding SA
PINK:ELVAF
|
0.187x |
Annual Cash Flow Conversion Efficiency for Bioscience Animal Health PCL (2019–2024)
The table below shows the annual cash flow conversion efficiency of Bioscience Animal Health PCL from 2019 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ฿813.73 Million | ฿104.40 Million | 0.128x | +549.54% |
| 2023-12-31 | ฿790.50 Million | ฿-22.56 Million | -0.029x | +33.00% |
| 2022-12-31 | ฿768.55 Million | ฿-32.74 Million | -0.043x | -130.95% |
| 2021-12-31 | ฿266.82 Million | ฿36.73 Million | 0.138x | +30.69% |
| 2020-12-31 | ฿212.85 Million | ฿22.42 Million | 0.105x | -94.86% |
| 2019-12-31 | ฿89.07 Million | ฿182.56 Million | 2.050x | -- |